Delaying Diabetes Progression After Impaired Glucose Improves Long-Term Outcomes
Significant risk reduction for death and vascular complications seen with maintaining at least four years of nondiabetes
Second Recipient of Genetically Modified Pig Kidney Has Died
Semaglutide Cuts MACE in People With Overweight, Obesity, Regardless of HbA1c
Reduction seen in cardiovascular events irrespective of baseline HbA1c or change in HbA1c
Racial, Ethnic, Economic Disparities Identified in Adoption of PCI Services
Hospitals serving communities with large proportion of Black, Hispanic residents, residential segregation less likely to adopt PCI services
ACEi, ARB Use Linked to Lower Risk for Kidney Failure With Replacement Therapy
Risk for kidney failure with replacement therapy lower with ACEi, ARB treatment among individuals with advanced CKD
Significantly More Weight Loss Seen With Tirzepatide Versus Semaglutide
Patients with overweight, obesity receiving tirzepatide significantly more likely to achieve ≥5, ≥10, and ≥15 percent weight loss
Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-Fib
Initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage
Almost Half of U.S. Counties Do Not Have Practicing Cardiologist
Counties without a cardiologist have higher cardiovascular risk index, higher cardiovascular mortality rates, and shorter life expectancy
Postpandemic Physician Revenue Recovery Varies by Specialty, Practice Type
Pathology, psychiatry revenue experienced robust recovery by 2022; surgery, oncology revenue remained at or below baseline
342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023
94.7 percent of the acquisitions occurred during 2021 to 2023; acquisition less likely in highest poverty communities
